Article History
Received: 18 September 2022
Revised: 28 November 2022
Accepted: 28 November 2022
First Online: 20 December 2022
Declarations
:
: AG: received consultancy fees from Pfizer, Novartis, MerckSerono, TissueGene, AstraZeneca, and Regeneron. He is a shareholder of Boston Imaging Core Lab., LLC. FWR: Consultant to Calibr and GrĂĽnenthal. He is a shareholder of Boston Imaging Core Lab., LLC. CKK has received consultancy fees from Thuasne, Regeneron, Novartis, Kolon Tissue Gene, Taiwan Liposome, Amzell AZ, LG Chem, Express Scripts, and has received grants from Lilly, Pfizer GSK, Cumberland.